Small Extracellular Vesicles in the Pericardium Modulate Macrophage Immunophenotype in Coronary Artery Disease.

coronary artery disease macrophages miRNAs pericardial fluid small extracellular vesicles

Journal

JACC. Basic to translational science
ISSN: 2452-302X
Titre abrégé: JACC Basic Transl Sci
Pays: United States
ID NLM: 101677259

Informations de publication

Date de publication:
Sep 2024
Historique:
received: 17 01 2024
revised: 10 05 2024
accepted: 10 05 2024
medline: 24 10 2024
pubmed: 24 10 2024
entrez: 24 10 2024
Statut: epublish

Résumé

Coronary artery disease (CAD) is a major health issue. This study focused on pericardial macrophages and small extracellular vesicles (sEVs) in CAD. The macrophages in CAD patients showed reduced expression of protective markers and unchanged levels of proinflammatory receptors. Similar changes were observed in buffy-coat-derived macrophages when stimulated with CAD pericardial fluid-derived sEVs. The sEV contained miRNA-6516-5p, which inhibited CD36 and affected macrophage lipid uptake. These findings indicate that sEV-mediated miRNA actions contribute to the decrease in protective pericardial macrophages in CAD.

Identifiants

pubmed: 39444932
doi: 10.1016/j.jacbts.2024.05.003
pii: S2452-302X(24)00188-8
pmc: PMC11494395
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1057-1072

Informations de copyright

© 2024 The Authors.

Déclaration de conflit d'intérêts

This study was supported by the British Heart Foundation (BHF) Programme Grant-RG/15/5/31446 and Personal Chair Awards-CH/15/1/31199 (to Dr Emanueli); BHF Transitional Fellowship (Imperial College London BHF Centre of Research Excellence-RE/18/4/34215) and BHF Project Grant (BHF- PG/23/11336) (both to Dr Ben-Aicha); UKRI Postdoctoral Fellowship-EP/X023729/1 (to Dr Martino); a grant from The Leducq Foundation (to Dr Sattler); PLEC2021–007664-Unión Europea NextGeneration EU/PRTR, grant PID2021-128891OB-I00, and grant M-ERA-NET-3 / PCI2023-143431 - European Funds (all to Dr Vilahur). This study was also funded by MCIN/AEI/10.13039/501100011033 and Fondo Europeo de Desarrollo Regional, A way of making Europe. This manuscript was also supported by the UK National Institute of Heart Research (NIHR) for funding this research. The authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Auteurs

Soumaya Ben-Aicha (S)

National Heart and Lung Institute, Imperial College London, London, United Kingdom.

Maryam Anwar (M)

National Heart and Lung Institute, Imperial College London, London, United Kingdom.

Gemma Vilahur (G)

Cardiovascular Program-ICCC, IR-Hospital Santa Creu i Sant Pau, IIB-Sant Pau, Barcelona, Spain.

Fabiana Martino (F)

National Heart and Lung Institute, Imperial College London, London, United Kingdom.

Panagiotis G Kyriazis (PG)

National Heart and Lung Institute, Imperial College London, London, United Kingdom.
Hammersmith Hospital, Imperial College Healthcare National Health Service Trust, London, United Kingdom.

Natasha de Winter (N)

National Heart and Lung Institute, Imperial College London, London, United Kingdom.

Prakash P Punjabi (PP)

National Heart and Lung Institute, Imperial College London, London, United Kingdom.
Cardiovascular Program-ICCC, IR-Hospital Santa Creu i Sant Pau, IIB-Sant Pau, Barcelona, Spain.

Gianni D Angelini (GD)

National Heart and Lung Institute, Imperial College London, London, United Kingdom.
Hammersmith Hospital, Imperial College Healthcare National Health Service Trust, London, United Kingdom.
Bristol Heart Institute, University of Bristol, Bristol, United Kingdom.

Susanne Sattler (S)

National Heart and Lung Institute, Imperial College London, London, United Kingdom.
Department of Pharmacology, Otto-Loewi Research Center, Medical University of Graz, Graz, Austria.
Department of Cardiology, Medical University of Graz, Graz, Austria.

Costanza Emanueli (C)

National Heart and Lung Institute, Imperial College London, London, United Kingdom.

Classifications MeSH